董事介绍
注：董事持股数取自最新公司公告
| 姓名 | 性别 | 职位 | 年龄 | 薪酬 | 持股数(万股) | 截止日期 |
|---|---|---|---|---|---|---|
| David Kratochvil | 男 | Chairman of the Board | 60 | 63.80万美元 | 5.69 | 2026-04-15 |
| Mike Schmidt | 男 | Chief Executive Officer and Director | 56 | 未披露 | 未持股 | 2026-04-15 |
| Elsa Sung | 女 | Independent Director | 52 | 未披露 | 未持股 | 2026-04-15 |
| Ashissh Raichura | 男 | Independent Director | 53 | 19.25万美元 | 5.00 | 2026-04-15 |
| Lillian Mbeki | 女 | Independent Director | 48 | 63.80万美元 | 1.00 | 2026-04-15 |
| Mike Schmidt | 男 | Chief Executive Officer and Director | 56 | 27.90万美元 | 未持股 | 2026-04-15 |
| Elsa Sung | 女 | Independent Director | 52 | 64.40万美元 | 5.69 | 2026-04-15 |
高管介绍
注：高管持股数取自最新公司公告
| 姓名 | 性别 | 职位 | 年龄 | 薪酬 | 持股数(万股) | 截止日期 |
|---|---|---|---|---|---|---|
| Mike Schmidt | 男 | Chief Executive Officer and Director | 56 | 27.90万美元 | 未持股 | 2026-04-15 |
| MeiLin Yu | 女 | Chief Financial Officer | 55 | 1.40万美元 | 未持股 | 2026-04-15 |
董事简历
中英对照 | 中文 | 英文- David Kratochvil
-
David Kratochvil，他将担任首席财务官和财务主管。他拥有20年以上的成功投资经验，涉及发达国家和新兴市场股票、固定收益，以及大宗商品的外汇投资和私人股本投资。任职Euro Pacific Capital公司期间，他曾担任公司的财务部门的董事总经理，负责监管公司的跨多种行业投资银行工作。此外，他曾担任Omega Advisors公司（数十亿美元的对冲基金）的国际证券商，在那里他曾投资于国际股票、新兴市场债券、货币和大宗商品。加入Omega公司之前，他曾担任 Merrill Lynch Asset Management公司（位于伦敦）的董事，在那里他负责新兴市场投资。他还经营Vista Capital Advisors公司（自己的咨询公司），担任纽约股票分析师、布拉格私人股本投资者、纽约营业税顾问。他持有the University of Chicago’s Booth School of Business的财务和国际业务方向的工商管理硕士学位、 The Wharton School at the University of Pennsylvania的经济学学士学位（双修金融和会计）。他拥有FINRA系列7、24、63、79、86和87许可证。
David Kratochvil has been serving on the Board since January 2025. Mr. Kratochvil has over thirty years of Wall Street experience ranging from venture capital, private equity and emerging market equity investing to investment banking and structuring tax advantaged deals. Since January 2017, Mr. Kratochvil has served as the managing partner of Vista Capital Advisors, where he consults on various projects and serves as an outsourced chief financial officer for early stage companies. Since April 2024, he has also served as chief financial officer of Pertexa Health Tech Inc. From April 2023 until April 2024, Mr. Kratochvil served as chief financial officer of Northann Corp (NYSE: NCL). Since January 2020, he has also served as Managing Director of Kenmar Securities, LLC, an investment bank focusing on life science, technology and real estate transactions. From January 2019 until December 2021, Mr. Kratochvil served as Chief Executive Officer of Ikigai Biotech Group, Inc., a development stage biotechnology company focused on using 3D bioprinting to address Type 1 diabetes and kidney disease. From June 2017 until December 2019, he served at Oberon Securities as a Managing Director focusing on healthcare and life science transactions. From 2015 until 2017, he served as chief financial officer of VolitionRx Limited (NYSE American: VNRX), a multinational medical diagnostics company developing blood based tests for the diagnosis of cancers. From 2008 until 2015, he served as a Managing Director in the corporate finance department at Euro Pacific Capital, Inc. From 1997 until 1999, he served as a portfolio manager at Omega Advisors, and from 1994 until 1997, he served as a director at Merrill Lynch Asset Management. Mr. Kratochvil holds an M.B.A. in finance and international business from the University of Chicago Booth School of Business and a B.S. in Economics from the Wharton School of the University of Pennsylvania. He also holds FINRA Series 7, 14, 24, 63, 79, 86 and 87 registrations. - David Kratochvil，他将担任首席财务官和财务主管。他拥有20年以上的成功投资经验，涉及发达国家和新兴市场股票、固定收益，以及大宗商品的外汇投资和私人股本投资。任职Euro Pacific Capital公司期间，他曾担任公司的财务部门的董事总经理，负责监管公司的跨多种行业投资银行工作。此外，他曾担任Omega Advisors公司（数十亿美元的对冲基金）的国际证券商，在那里他曾投资于国际股票、新兴市场债券、货币和大宗商品。加入Omega公司之前，他曾担任 Merrill Lynch Asset Management公司（位于伦敦）的董事，在那里他负责新兴市场投资。他还经营Vista Capital Advisors公司（自己的咨询公司），担任纽约股票分析师、布拉格私人股本投资者、纽约营业税顾问。他持有the University of Chicago’s Booth School of Business的财务和国际业务方向的工商管理硕士学位、 The Wharton School at the University of Pennsylvania的经济学学士学位（双修金融和会计）。他拥有FINRA系列7、24、63、79、86和87许可证。
- David Kratochvil has been serving on the Board since January 2025. Mr. Kratochvil has over thirty years of Wall Street experience ranging from venture capital, private equity and emerging market equity investing to investment banking and structuring tax advantaged deals. Since January 2017, Mr. Kratochvil has served as the managing partner of Vista Capital Advisors, where he consults on various projects and serves as an outsourced chief financial officer for early stage companies. Since April 2024, he has also served as chief financial officer of Pertexa Health Tech Inc. From April 2023 until April 2024, Mr. Kratochvil served as chief financial officer of Northann Corp (NYSE: NCL). Since January 2020, he has also served as Managing Director of Kenmar Securities, LLC, an investment bank focusing on life science, technology and real estate transactions. From January 2019 until December 2021, Mr. Kratochvil served as Chief Executive Officer of Ikigai Biotech Group, Inc., a development stage biotechnology company focused on using 3D bioprinting to address Type 1 diabetes and kidney disease. From June 2017 until December 2019, he served at Oberon Securities as a Managing Director focusing on healthcare and life science transactions. From 2015 until 2017, he served as chief financial officer of VolitionRx Limited (NYSE American: VNRX), a multinational medical diagnostics company developing blood based tests for the diagnosis of cancers. From 2008 until 2015, he served as a Managing Director in the corporate finance department at Euro Pacific Capital, Inc. From 1997 until 1999, he served as a portfolio manager at Omega Advisors, and from 1994 until 1997, he served as a director at Merrill Lynch Asset Management. Mr. Kratochvil holds an M.B.A. in finance and international business from the University of Chicago Booth School of Business and a B.S. in Economics from the Wharton School of the University of Pennsylvania. He also holds FINRA Series 7, 14, 24, 63, 79, 86 and 87 registrations.
- Mike Schmidt
-
迈克·施密特（Mike Schmidt），在通信行业拥有超过二十年的职业生涯。2021年1月至2025年5月，任生物医药研究公司业务拓展副总裁。从2014年5月到2016年8月，施密特先生担任Urban Communications Inc.（UrbanFibre）总裁。2012年12月至2014年4月，他在Teliphone Navigata Westel担任业务发展副总裁。2009年7月至2012年12月，任Uniserve Communications首席执行官。施密特先生拥有圭尔夫大学的学士学位。
Mike Schmidt serves as the Chief Executive Officer of the Company and as a member of the board of directors. He has more than two decades in the communications and telecommunications industries. From January 2021 until May 2025, he served as Vice President of Business Development at Biologic Pharmamedical Research. From May 2014 until August 2016, Mr. Schmidt served as President of Urban Communications Inc., or Urbanfibre. Previously, he served as Vice President of Business Development at Teliphone Navigata Westel from December 2012 to April 2014. From July 2009 to December 2012, he served as Chief Executive Officer of Uniserve Communications. Mr. Schmidt holds a Bachelor of Arts degree from the University of Guelph. - 迈克·施密特（Mike Schmidt），在通信行业拥有超过二十年的职业生涯。2021年1月至2025年5月，任生物医药研究公司业务拓展副总裁。从2014年5月到2016年8月，施密特先生担任Urban Communications Inc.（UrbanFibre）总裁。2012年12月至2014年4月，他在Teliphone Navigata Westel担任业务发展副总裁。2009年7月至2012年12月，任Uniserve Communications首席执行官。施密特先生拥有圭尔夫大学的学士学位。
- Mike Schmidt serves as the Chief Executive Officer of the Company and as a member of the board of directors. He has more than two decades in the communications and telecommunications industries. From January 2021 until May 2025, he served as Vice President of Business Development at Biologic Pharmamedical Research. From May 2014 until August 2016, Mr. Schmidt served as President of Urban Communications Inc., or Urbanfibre. Previously, he served as Vice President of Business Development at Teliphone Navigata Westel from December 2012 to April 2014. From July 2009 to December 2012, he served as Chief Executive Officer of Uniserve Communications. Mr. Schmidt holds a Bachelor of Arts degree from the University of Guelph.
- Elsa Sung
-
Elsa Sung拥有20多年的财务会计经验，其中曾担任纳斯达克上市公司的首席财务官。自2017年2月以来，她一直担任财务咨询和咨询公司Canvas Group，Inc.的管理成员。她此前曾在江波制药有限责任公司（TERM1：JCBO）担任首席财务官，并曾在Ernst & Young LLP和Sherb & Co担任审计职务。Sung女士拥有佛罗里达大西洋大学的MBA和会计学理学学士学位。她是佐治亚州的持牌注册会计师（非在职）。她自2025年1月起担任Nixxy，Inc.的董事。
Elsa Sung has more than 20 years of financial and accounting experience, including serving as Chief Financial Officer of a Nasdaq listed company. Since February 2017, she has been a Managing Member of Canvas Group, Inc., a financial advisory and consulting firm. She previously served as Chief Financial Officer of Jiangbo Pharmaceuticals, Inc. (Nasdaq: JCBO) and held audit roles at Ernst & Young LLP and Sherb & Co. Ms. Sung holds an MBA and a Bachelor of Science in Accounting from Florida Atlantic University. She is a licensed CPA in the State of Georgia (inactive). She has served as Nixxy, Inc.'s Director since January 2025. - Elsa Sung拥有20多年的财务会计经验，其中曾担任纳斯达克上市公司的首席财务官。自2017年2月以来，她一直担任财务咨询和咨询公司Canvas Group，Inc.的管理成员。她此前曾在江波制药有限责任公司（TERM1：JCBO）担任首席财务官，并曾在Ernst & Young LLP和Sherb & Co担任审计职务。Sung女士拥有佛罗里达大西洋大学的MBA和会计学理学学士学位。她是佐治亚州的持牌注册会计师（非在职）。她自2025年1月起担任Nixxy，Inc.的董事。
- Elsa Sung has more than 20 years of financial and accounting experience, including serving as Chief Financial Officer of a Nasdaq listed company. Since February 2017, she has been a Managing Member of Canvas Group, Inc., a financial advisory and consulting firm. She previously served as Chief Financial Officer of Jiangbo Pharmaceuticals, Inc. (Nasdaq: JCBO) and held audit roles at Ernst & Young LLP and Sherb & Co. Ms. Sung holds an MBA and a Bachelor of Science in Accounting from Florida Atlantic University. She is a licensed CPA in the State of Georgia (inactive). She has served as Nixxy, Inc.'s Director since January 2025.
- Ashissh Raichura
-
Ashishh Raichura是一位经验丰富的企业家和技术专家，在产品开发、电信和医疗保健创新方面拥有30多年的全球经验。自2017年1月起，担任Scanbo创始人兼首席执行官，Scanbo是一家集人工智能和生物传感器技术于一体的护理点诊断平台。他此前曾担任高级技术领导职务，包括HealthSaverz.com的首席技术官和Temple Consulting Group Ltd.的产品开发和技术副总裁。Raichura先生在领导全球市场的复杂技术计划方面拥有丰富的经验。拥有Simon Fraser大学云计算博士学位和高级物联网解决方案认证。他自2025年4月起担任Nixxy，Inc.的董事。
Ashissh Raichura is a seasoned entrepreneur and technologist with more than 30 years of global experience in product development, telecommunications, and healthcare innovation. Since January 2017, he has served as Founder and Chief Executive Officer of Scanbo, a point of care diagnostic platform integrating artificial intelligence and biosensor technologies. He previously held senior technology leadership roles, including Chief Technology Officer at HealthSaverz.com and Vice President of Product Development and Technology at Temple Consulting Group Ltd. Mr. Raichura has extensive experience leading complex technology initiatives across global markets. He holds a Ph.D. in Cloud Computing from Simon Fraser University and certifications in Advanced IoT Solutions. He has served as Nixxy, Inc.'s Director since April 2025. - Ashishh Raichura是一位经验丰富的企业家和技术专家，在产品开发、电信和医疗保健创新方面拥有30多年的全球经验。自2017年1月起，担任Scanbo创始人兼首席执行官，Scanbo是一家集人工智能和生物传感器技术于一体的护理点诊断平台。他此前曾担任高级技术领导职务，包括HealthSaverz.com的首席技术官和Temple Consulting Group Ltd.的产品开发和技术副总裁。Raichura先生在领导全球市场的复杂技术计划方面拥有丰富的经验。拥有Simon Fraser大学云计算博士学位和高级物联网解决方案认证。他自2025年4月起担任Nixxy，Inc.的董事。
- Ashissh Raichura is a seasoned entrepreneur and technologist with more than 30 years of global experience in product development, telecommunications, and healthcare innovation. Since January 2017, he has served as Founder and Chief Executive Officer of Scanbo, a point of care diagnostic platform integrating artificial intelligence and biosensor technologies. He previously held senior technology leadership roles, including Chief Technology Officer at HealthSaverz.com and Vice President of Product Development and Technology at Temple Consulting Group Ltd. Mr. Raichura has extensive experience leading complex technology initiatives across global markets. He holds a Ph.D. in Cloud Computing from Simon Fraser University and certifications in Advanced IoT Solutions. He has served as Nixxy, Inc.'s Director since April 2025.
- Lillian Mbeki
-
Lillian Mbeki自2013年7月起担任ELLEM Marketing & Communications LTD首席执行官。她带来了战略传播和业务发展方面的高管领导经验。Mbeki女士拥有爱丁堡商学院的工商管理博士学位和MBA学位，肯雅塔大学的卫生系统管理理学硕士学位，以及内罗毕大学的护理理学学士学位。她自2024年3月起担任董事会成员。
Lillian Mbeki has served as Chief Executive Officer of ELLEM Marketing & Communications LTD since July 2013. She has executive leadership experience in strategic communications and business development. Ms. Mbeki holds a Doctorate in Business Administration and an MBA from Edinburgh Business School, a Master of Science in Health Systems Management from Kenyatta University, and a Bachelor of Science in Nursing from the University of Nairobi. She has served on the Board since March 2024. - Lillian Mbeki自2013年7月起担任ELLEM Marketing & Communications LTD首席执行官。她带来了战略传播和业务发展方面的高管领导经验。Mbeki女士拥有爱丁堡商学院的工商管理博士学位和MBA学位，肯雅塔大学的卫生系统管理理学硕士学位，以及内罗毕大学的护理理学学士学位。她自2024年3月起担任董事会成员。
- Lillian Mbeki has served as Chief Executive Officer of ELLEM Marketing & Communications LTD since July 2013. She has executive leadership experience in strategic communications and business development. Ms. Mbeki holds a Doctorate in Business Administration and an MBA from Edinburgh Business School, a Master of Science in Health Systems Management from Kenyatta University, and a Bachelor of Science in Nursing from the University of Nairobi. She has served on the Board since March 2024.
- Mike Schmidt
-
Michal Schmidt自2025年5月起担任公司首席执行官，并自2025年7月起担任董事会成员。施密特在通信行业的职业生涯跨越了二十多年。2021年1月至2025年5月，在Biologic Pharmamedical Research担任BINES Development副总裁。从2014年5月到2016年8月，施密特先生担任Urban Communications Inc.（UrbanFibre）总裁。2012年12月至2014年4月，在Teliphone Navigata stel担任BINCE开发副总裁。2009年7月至2012年12月，任Uniserve Communications首席执行官。施密特先生拥有圭尔夫大学的学士学位。
Mike Schmidt has served as the Company's Chief Executive Officer since May 2025 and has served on the Board since July 2025. Mr. Schmidt has a career spanning over two decades in the communications industry. From January 2021 until May 2025, he served as the Vice President of Biness Development at Biologic Pharmamedical Research. From May 2014 until August 2016, Mr. Schmidt served as President of Urban Communications Inc., or Urbanfibre. From December 2012 until April 2014, he served as Vice President of Biness Development at Teliphone Navigata stel. From July 2009 until December 2012, he served as CEO of Uniserve Communications. Mr. Schmidt has a B.A. from the University of Guelph. - Michal Schmidt自2025年5月起担任公司首席执行官，并自2025年7月起担任董事会成员。施密特在通信行业的职业生涯跨越了二十多年。2021年1月至2025年5月，在Biologic Pharmamedical Research担任BINES Development副总裁。从2014年5月到2016年8月，施密特先生担任Urban Communications Inc.（UrbanFibre）总裁。2012年12月至2014年4月，在Teliphone Navigata stel担任BINCE开发副总裁。2009年7月至2012年12月，任Uniserve Communications首席执行官。施密特先生拥有圭尔夫大学的学士学位。
- Mike Schmidt has served as the Company's Chief Executive Officer since May 2025 and has served on the Board since July 2025. Mr. Schmidt has a career spanning over two decades in the communications industry. From January 2021 until May 2025, he served as the Vice President of Biness Development at Biologic Pharmamedical Research. From May 2014 until August 2016, Mr. Schmidt served as President of Urban Communications Inc., or Urbanfibre. From December 2012 until April 2014, he served as Vice President of Biness Development at Teliphone Navigata stel. From July 2009 until December 2012, he served as CEO of Uniserve Communications. Mr. Schmidt has a B.A. from the University of Guelph.
- Elsa Sung
-
Elsa Sung自2007年10月起担任公司的财务总监。在2008年6月之前，她也担任CFO Oncall股份有限公司（CFO Oncall, Inc）的副总裁。在加入CFO Oncall, Inc.之前，Sung女士是Sherb & Co.（位于佛罗里达州博卡拉顿（Boca Raton, Florida））审计经理（2006年1月-2007年7月），负责为国内和国际客户提供管理、监督、审计服务。2005年6月-2005年12月，她是Applica Consumer Products股份有限公司（Applica Consumer Products, Inc.，一家美国（U.S。）上市公司）的高级内部审计师。2002-2005年她是Ernst & Young有限责任合伙公司（Ernst & Young, LLP，位于佛罗里达西棕榈滩（West Palm Beach, Florida））担任担保及咨询服务集团的高级审计师。她是佐治亚州（State of Georgia）注册会计师，也是美国注册会计师协会（American Institute of Certified Public Accountants）的成员。她在佛罗里达大西洋大学（Florida Atlantic University）拥有工商管理硕士学位和会计学士学位（最高荣誉） 。她也拥有国立政治大学（位于台湾台北（Taipei, Taiwan））社会学学士学位。
Elsa Sung,has more than 20 years of financial and accounting experience, including serving as Chief Financial Officer of a Nasdaq-listed company. Since February 2017, she has been a Managing Member of Canvas Group, Inc., a financial advisory and consulting firm. She previously served as Chief Financial Officer of Jiangbo Pharmaceuticals, Inc. (Nasdaq: JCBO) and held audit roles at Ernst & Young LLP and Sherb & Co. Ms. Sung holds an MBA and a Bachelor of Science in Accounting from Florida Atlantic University. She is a licensed CPA in the State of Georgia (inactive). She has served as on the Board since January 2025. - Elsa Sung自2007年10月起担任公司的财务总监。在2008年6月之前，她也担任CFO Oncall股份有限公司（CFO Oncall, Inc）的副总裁。在加入CFO Oncall, Inc.之前，Sung女士是Sherb & Co.（位于佛罗里达州博卡拉顿（Boca Raton, Florida））审计经理（2006年1月-2007年7月），负责为国内和国际客户提供管理、监督、审计服务。2005年6月-2005年12月，她是Applica Consumer Products股份有限公司（Applica Consumer Products, Inc.，一家美国（U.S。）上市公司）的高级内部审计师。2002-2005年她是Ernst & Young有限责任合伙公司（Ernst & Young, LLP，位于佛罗里达西棕榈滩（West Palm Beach, Florida））担任担保及咨询服务集团的高级审计师。她是佐治亚州（State of Georgia）注册会计师，也是美国注册会计师协会（American Institute of Certified Public Accountants）的成员。她在佛罗里达大西洋大学（Florida Atlantic University）拥有工商管理硕士学位和会计学士学位（最高荣誉） 。她也拥有国立政治大学（位于台湾台北（Taipei, Taiwan））社会学学士学位。
- Elsa Sung,has more than 20 years of financial and accounting experience, including serving as Chief Financial Officer of a Nasdaq-listed company. Since February 2017, she has been a Managing Member of Canvas Group, Inc., a financial advisory and consulting firm. She previously served as Chief Financial Officer of Jiangbo Pharmaceuticals, Inc. (Nasdaq: JCBO) and held audit roles at Ernst & Young LLP and Sherb & Co. Ms. Sung holds an MBA and a Bachelor of Science in Accounting from Florida Atlantic University. She is a licensed CPA in the State of Georgia (inactive). She has served as on the Board since January 2025.
高管简历
中英对照 | 中文 | 英文- Mike Schmidt
Michal Schmidt自2025年5月起担任公司首席执行官，并自2025年7月起担任董事会成员。施密特在通信行业的职业生涯跨越了二十多年。2021年1月至2025年5月，在Biologic Pharmamedical Research担任BINES Development副总裁。从2014年5月到2016年8月，施密特先生担任Urban Communications Inc.（UrbanFibre）总裁。2012年12月至2014年4月，在Teliphone Navigata stel担任BINCE开发副总裁。2009年7月至2012年12月，任Uniserve Communications首席执行官。施密特先生拥有圭尔夫大学的学士学位。
Mike Schmidt has served as the Company's Chief Executive Officer since May 2025 and has served on the Board since July 2025. Mr. Schmidt has a career spanning over two decades in the communications industry. From January 2021 until May 2025, he served as the Vice President of Biness Development at Biologic Pharmamedical Research. From May 2014 until August 2016, Mr. Schmidt served as President of Urban Communications Inc., or Urbanfibre. From December 2012 until April 2014, he served as Vice President of Biness Development at Teliphone Navigata stel. From July 2009 until December 2012, he served as CEO of Uniserve Communications. Mr. Schmidt has a B.A. from the University of Guelph.- Michal Schmidt自2025年5月起担任公司首席执行官，并自2025年7月起担任董事会成员。施密特在通信行业的职业生涯跨越了二十多年。2021年1月至2025年5月，在Biologic Pharmamedical Research担任BINES Development副总裁。从2014年5月到2016年8月，施密特先生担任Urban Communications Inc.（UrbanFibre）总裁。2012年12月至2014年4月，在Teliphone Navigata stel担任BINCE开发副总裁。2009年7月至2012年12月，任Uniserve Communications首席执行官。施密特先生拥有圭尔夫大学的学士学位。
- Mike Schmidt has served as the Company's Chief Executive Officer since May 2025 and has served on the Board since July 2025. Mr. Schmidt has a career spanning over two decades in the communications industry. From January 2021 until May 2025, he served as the Vice President of Biness Development at Biologic Pharmamedical Research. From May 2014 until August 2016, Mr. Schmidt served as President of Urban Communications Inc., or Urbanfibre. From December 2012 until April 2014, he served as Vice President of Biness Development at Teliphone Navigata stel. From July 2009 until December 2012, he served as CEO of Uniserve Communications. Mr. Schmidt has a B.A. from the University of Guelph.
- MeiLin Yu
俞梅林是一位经验丰富的财务主管，拥有20多年领导上市和跨国组织的财务战略、资本市场举措和公司治理的经验。她在SEC报告、内部控制、并购以及跨技术驱动和受监管行业的企业转型方面拥有深厚的专业知识。2022年至2024年，她在一家纳斯达克上市金融科技公司担任首席财务官和财务主管，负责领导公共报告、资本市场交易、审计监督以及企业财务运营。2012年至2022年，她担任一家上市生物技术公司的董事和战略财务顾问，支持增长计划、重组努力和复杂的财务交易。在其职业生涯的早期，余女士曾在《财富》50强跨国公司担任高级财务领导职务，其中包括联合利华和埃克森美孚，负责监督全球会计业务、内部控制环境以及大规模的财务和技术转型计划。余女士拥有计算机系统学士学位和工商管理硕士学位（MBA）。她是注册会计师（CPA）、注册全球管理会计师（CGMA）、注册内部审计师（CIA）、六西格玛黑带。
Meilin Yu is a seasoned finance executive with more than 20 years of experience leading financial strategy, capital markets initiatives, and corporate governance for publicly traded and multinational organizations. She has deep expertise in SEC reporting, internal controls, mergers and acquisitions, and enterprise transformation across technology driven and regulated industries. From 2022 to 2024, she served as Chief Financial Officer and Treasurer of a Nasdaq listed financial technology company, where she led public reporting, capital markets transactions, audit oversight, and enterprise financial operations. From 2012 to 2022, she served as a director and strategic finance advisor to a publicly traded biotechnology company, supporting growth initiatives, restructuring efforts, and complex financial transactions. Earlier in her career, Ms. Yu held senior finance leadership roles at Fortune 50 multinational corporations, including Unilever and ExxonMobil, where she oversaw global accounting operations, internal control environments, and large scale financial and technology transformation initiatives. Ms. Yu holds a Bachelor's degree in Computer Systems and a Master of Business Administration (MBA). She is a Certified Public Accountant (CPA), Certified Global Management Accountant (CGMA), Certified Internal Auditor (CIA), and Six Sigma Black Belt.- 俞梅林是一位经验丰富的财务主管，拥有20多年领导上市和跨国组织的财务战略、资本市场举措和公司治理的经验。她在SEC报告、内部控制、并购以及跨技术驱动和受监管行业的企业转型方面拥有深厚的专业知识。2022年至2024年，她在一家纳斯达克上市金融科技公司担任首席财务官和财务主管，负责领导公共报告、资本市场交易、审计监督以及企业财务运营。2012年至2022年，她担任一家上市生物技术公司的董事和战略财务顾问，支持增长计划、重组努力和复杂的财务交易。在其职业生涯的早期，余女士曾在《财富》50强跨国公司担任高级财务领导职务，其中包括联合利华和埃克森美孚，负责监督全球会计业务、内部控制环境以及大规模的财务和技术转型计划。余女士拥有计算机系统学士学位和工商管理硕士学位（MBA）。她是注册会计师（CPA）、注册全球管理会计师（CGMA）、注册内部审计师（CIA）、六西格玛黑带。
- Meilin Yu is a seasoned finance executive with more than 20 years of experience leading financial strategy, capital markets initiatives, and corporate governance for publicly traded and multinational organizations. She has deep expertise in SEC reporting, internal controls, mergers and acquisitions, and enterprise transformation across technology driven and regulated industries. From 2022 to 2024, she served as Chief Financial Officer and Treasurer of a Nasdaq listed financial technology company, where she led public reporting, capital markets transactions, audit oversight, and enterprise financial operations. From 2012 to 2022, she served as a director and strategic finance advisor to a publicly traded biotechnology company, supporting growth initiatives, restructuring efforts, and complex financial transactions. Earlier in her career, Ms. Yu held senior finance leadership roles at Fortune 50 multinational corporations, including Unilever and ExxonMobil, where she oversaw global accounting operations, internal control environments, and large scale financial and technology transformation initiatives. Ms. Yu holds a Bachelor's degree in Computer Systems and a Master of Business Administration (MBA). She is a Certified Public Accountant (CPA), Certified Global Management Accountant (CGMA), Certified Internal Auditor (CIA), and Six Sigma Black Belt.